Immunostep
IMMUNOSTEP is a Spanish Biotech company that researches, optimizes, manufactures and sells reagents for its use for diagnosis and clinical research by flow cytometry. Additionally, IMMUNOSTEP offers custom antibody development services, including monoclonal and polyclonal antibody generation, antibody production and manipulation.
View all Immunostep Products
CAR T cell therapy from Immunostep
CAR T cell therapy is based on the removal of T cells from the patient, the introduction of a specific Chimeric Antigen Receptor (CAR) of a protein present on cancer cells (e.g., CD19), and the subsequent reinfusion of these modified cells, now called CAR T cells, into the patient so that they recognize the target cells and eliminate them.
This therapy has become relevant due to its effectiveness, so CAR T cell detection tools have become a critical need, both to check that they have been modified correctly and to monitor them after reinfusion, since they have a limited shelf life.

Cell Type | Cytokines | FISI Medium |
T Cells | IL-2/7/10/15/21 | T cell CDM-91154 |
T cell XSFM-91141 | ||
NK | IL-2/7/15 | NK CDM-91215 |
DC | M-CSF | DC CDM-91146 |
IL-6/10/IL-4 | T cell CDM-91154 | |
T cell XSFM-91141 | ||
HSC | FLT-3 Ligand; IL-3, IL-6, IL-4, GM-CSF, M-CSF | HCS-91211 |
Alpha MEM Earle's Salts w/o Nucleosides - Liquid 9142 | ||
Alpha MEM Earle's Salts - Liquid-9144 | ||
MSC | PDGF-BB/GM-CSF | DME High Glucose w/o L-Glutamine - Liquid - 9024 |
DME High Glucose - Liquid-9031 | ||
MSC. Neural cell | PDGF-AA, EGF | PRIME-XV MSC Expansion XSFM- 91149 |
PRIME-XV FreezIS- 91149 | ||
PRIME-XV Neural Basal Medium- 91201 |